Department of Global Health, Boston University School of Public Health, Boston, MA, USA.
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
BMC Public Health. 2019 Jul 22;19(1):973. doi: 10.1186/s12889-019-7257-4.
Gauteng Province has the second lowest tuberculosis (TB) incidence rate in South Africa but the greatest proportion of TB/HIV co-infection, with 68% of TB patients estimated to have HIV. TB treatment outcomes are well documented at the national and provincial level; however, knowledge gaps remain on how outcomes differ across detailed age groups.
Using data from South Africa's National Electronic TB Register (ETR), we assessed all-cause mortality and loss to follow-up (LTFU) among patients initiating treatment for TB between 01/2010 and 12/2015 in the metropolitan municipalities of Ekurhuleni Metropolitan Municipality and the City of Johannesburg in Gauteng Province. We excluded patients who were missing age, had known drug-resistance, or transferred into TB care from sites outside the two metropolitan municipalities. Among patients assigned a treatment outcome, we investigated the association between age group at treatment initiation and mortality or LTFU (treatment interruption of ≥2 months) within 10 months after treatment initiation using Cox proportional hazard models and present hazard ratios and Kaplan-Meier survival curves.
We identified 182,890 children (<10 years), young adolescent (10-14), older adolescent (15-19), young adult (20-24), adult (25-49), and older adult (≥50) TB cases without known drug-resistance. ART coverage among HIV co-infected patients was highest for young adolescents (64.3%) and lowest for young adults (54.0%) compared to other age groups (all over 60%). Treatment success exceeded 80% in all age groups (n = 170,017). All-cause mortality increased with age. Compared to adults, young adults had an increased hazard of LTFU (20-24 vs 25-49 years; aHR 1.43 95% CI: 1.33, 1.54) while children, young adolescents, and older adults had lower hazard of LTFU. Patients with HIV on ART had a lower risk of LTFU, but greater risk of death when compared to patients without HIV.
Young adults in urban areas of Gauteng Province experience a disproportionate burden of LTFU and low coverage of ART among co-infected patients. This group should be targeted for interventions aimed at improving clinical outcomes and retention in both TB and HIV care.
豪登省是南非第二低结核病(TB)发病率的省份,但 HIV 合并感染的比例最高,估计有 68%的 TB 患者感染 HIV。国家和省级结核病治疗结果有很好的记录;然而,对于不同详细年龄组的结果如何不同,仍存在知识差距。
利用南非国家电子结核病登记处(ETR)的数据,我们评估了 2010 年 1 月至 2015 年 12 月期间在豪登省埃库鲁莱尼大都市区和约翰内斯堡市启动 TB 治疗的患者的全因死亡率和失访(LTFU)。我们排除了年龄缺失、已知耐药性或从大都市以外的地点转入 TB 护理的患者。在分配治疗结果的患者中,我们使用 Cox 比例风险模型调查了治疗开始时的年龄组与治疗开始后 10 个月内死亡率或 LTFU(治疗中断≥2 个月)之间的关系,并呈现危险比和 Kaplan-Meier 生存曲线。
我们确定了 182890 名儿童(<10 岁)、青少年(10-14 岁)、青年(15-19 岁)、年轻成年人(20-24 岁)、成年人(25-49 岁)和老年人(≥50 岁)未发现已知耐药性的 TB 病例。与其他年龄组相比,HIV 合并感染患者的 ART 覆盖率在青少年中最高(64.3%),在年轻成年人中最低(54.0%)。所有年龄组的治疗成功率均超过 80%(n=170017)。全因死亡率随年龄增长而增加。与成年人相比,年轻成年人 LTFU 的风险增加(20-24 岁与 25-49 岁;aHR 1.43 95%CI:1.33,1.54),而儿童、青少年和老年人 LTFU 的风险较低。与未感染 HIV 的患者相比,接受 ART 治疗的 HIV 患者 LTFU 的风险较低,但死亡风险较高。
豪登省城市地区的年轻成年人面临不成比例的 LTFU 和 HIV 合并感染患者 ART 覆盖率低的负担。应针对这一人群采取干预措施,以改善 TB 和 HIV 护理的临床结局和保留率。